Purchases and Sales Made in Q4 2024 in Neurosense Therapeutics LTD Wt (NRSNW)
This table provides information about the institutional ownership of Neurosense Therapeutics LTD Wt (NRSNW) during Q4 2024. The information is specifically focused on institutions that hold shares of NEUROSENSE THERAPEUTICS LTD WT.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Clear Street LLC
|
SELL
|
- |
-100- 0.15% |
$12 - $50
|
65.7K
$14.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
SELL
|
- |
-106- 53.0% |
$12.7 - $53
|
94
$20.7
|
|
|
Feb 13, 2025
Q4 2024
|
Warberg Asset Management LLC
Winnetka, IL |
SELL
|
- |
-2.27K- 11.21% |
$272 - $1.13K
|
17.9K
$3.95K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-2.56K- 10.14% |
$308 - $1.28K
|
22.7K
$5K
|